Global menu

Our global pages


Eversheds Sutherland advises Medica Group on its Main Market IPO

  • Global


    Eversheds Sutherland has advised the UK market leader in teleradiology, Medica Group plc, on its initial public offering (IPO) on the London Stock Exchange, valuing the company at £150 million.

    As part of the IPO, Medica’s major selling shareholder, CBPE Capital LLP, sold the majority of its stake in Medica and retained approximately 11% in the company which it had acquired from Nuffield Health in May 2013.

    The Eversheds team on the transaction was led by partners Sebastian Orton and Richard Moulton assisted by lead associate Jon Stanley. Other members of the team included Chris Brough and Hugh Wilkinson (Corporate), Danny Blum and Victoria Gree (Options) and Patrick Davis (Banking).

    This information is for guidance purposes only and should not be regarded as a substitute for taking legal advice. Please refer to the full terms and conditions on our website.

    < Go back